DongKoo Bio & Pharma Co., Ltd. (KOSDAQ:006620)
South Korea · Delayed Price · Currency is KRW 4,835.00
-155.00 (-3.11%)
At close: May 11, 2026
DongKoo Bio & Pharma Market Cap
DongKoo Bio & Pharma has a market cap or net worth of 130.75 billion as of May 11, 2026. Its market cap has decreased by -12.73% in one year.
Market Cap
130.75B
Enterprise Value
224.82B
Revenue
242.69B
Ranking
n/a
PE Ratio
2.70
Stock Price
4,835.00
Market Cap Chart
Since February 19, 2018, DongKoo Bio & Pharma's market cap has decreased from 369.75B to 130.75B, a decrease of -64.64%. That is a compound annual growth rate of -11.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 130.75B | -11.61% |
| Dec 30, 2025 | 147.92B | 12.87% |
| Dec 30, 2024 | 131.05B | -16.18% |
| Dec 28, 2023 | 156.35B | -7.82% |
| Dec 29, 2022 | 169.61B | -27.07% |
| Dec 30, 2021 | 232.56B | -3.34% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 19, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| High Tech Pharm | 170.34B |
| OPTUS Pharmaceutical | 150.88B |
| Kyung Dong Pharmaceutical | 149.26B |
| PHARMARESEARCH BIO | 146.33B |
| Cosmax Nbt | 139.57B |
| HYUNDAI BIOLAND | 134.25B |
| Organoidsciences | 130.13B |
| KOREA PHARMA | 120.85B |